In 2020, the District of Columbia had the highest teenage pregnancy rate in the United States, followed by Mississippi and Arkansas. At that time, there were around 45 pregnancies among teens aged 15 to 19 per 1,000 in the District of Columbia. Teenage pregnancy Teenage pregnancy rates in the United States have decreased in recent years. In 2020, there were around 26.7 teenage pregnancies per 1,000 women aged 15 to 19 years. This number was almost 118 per 1,000 women in the year 1990. It is believed that the causes of this decrease include more teens abstaining from sex and increased use of birth control among those teens who are sexually active. Contraception use The use of contraception among sexually active teens is vital in reducing the rates of teen pregnancy. However, in 2021, only 52 percent of sexually active teens reported they used a condom during their last sexual intercourse. Furthermore, only 23 percent of sexually active female high school students were using the birth control bill to prevent pregnancy. Access to contraception and taboos surrounding teen sexual activity remain barriers to contraceptive use among teens in many areas of the United States.
In 2023, the birth rate among teenagers and young adult women aged 15 to 19 stood at 13.1 births per every thousand women. This statistic shows the U.S. birth rate among teenagers and young adult women, aged 15-19 years, between 1991 and 2023. Teenage pregnancy and birth Teenage pregnancy and births are related to a number of negative outcomes. Babies born to teenage mothers are more likely to be premature and have a low birth weight, and teen mothers often experience gestational hypertension and anemia. Additionally, there are significant adverse effects on socioeconomic and educational outcomes for teenage parents. Teenage pregnancy is usually unplanned and due to the negative consequences mentioned above the ratio of legal abortions to live births in the United States is highest among teenagers. In 2022, there were 374 legal abortions per 1,000 live births among girls and young women aged 15 to 19 years, compared a ratio of 284 legal abortions per 1,000 live births among women aged 20 to 24 years. Contraceptive use among teens Contraceptive use is the best way for sexually active teenagers to avoid unwanted pregnancies, but use and accessibility remain problems in the United States. In 2021, only 23 percent of high school girls in the U.S. used the birth control pill to prevent pregnancy before their last sexual intercourse. Use of the birth control pill to prevent pregnancy is highest among white teenagers and lowest among Black teenagers, with only 11 percent of Black teenagers reporting use in 2021. Condom use is more common among high school students, but still only around half of sexually active students reported using a condom during their last sexual intercourse in 2021.
This statistic shows the results of a survey among American female teenagers conducted from 2015 to 2017 on their choice of contraception during their sexual intercourse. Some 97 percent of females surveyed stated that they had used a condom during sexual encounter to protect themselves.
https://www.technavio.com/content/privacy-noticehttps://www.technavio.com/content/privacy-notice
Female Contraceptive Market Size 2024-2028
The female contraceptive market size is forecast to increase by USD 4.57 billion at a CAGR of 4.6% between 2023 and 2028. The market is experiencing significant growth due to several key factors. One trend is the increasing preference for contemporary contraceptive methods among teenagers and young populations, aiming to reduce unplanned pregnancies. Married women also continue to seek reliable and effective birth control options, leading to the popularity of various methods such as birth control pill, intrauterine devices (IUDs), and condoms. IUDs, in particular, have gained traction due to their long-term effectiveness and convenience. Hormonal IUDs and nonhormonal IUDs offer different advantages, with hormonal IUDs providing continuous hormonal release and nonhormonal IUDs offering a hormone-free alternative. However, there are challenges to address, such as irregularities in sex education in developed countries, which may result in misconceptions and incorrect usage of contraceptives. Additionally, surgery-related procedures for IUD insertion may deter some individuals from adopting this method. Overall, the market is driven by the need for effective and convenient contraceptive solutions for women.
Request Free Sample
The market is a significant sector within the healthcare industry, catering to the reproductive health needs of a substantial portion of the global female population. The market encompasses a diverse range of products, including intrauterine devices (IUDs), oral contraceptives, transdermal patches, vaginal gels, contraceptive injections, spermicides, female condoms, diaphragms and caps, and various other medications. The demand for contemporary contraceptives continues to grow as more women seek reliable and effective methods to prevent unplanned pregnancies. According to recent studies, the young population and teenagers represent a substantial portion of this demand.
Furthermore, the contraceptive pipeline is rich with new developments. For instance, dienogest + ethinylestradiol and Estelle (drospirenone + estetrol) are two promising oral contraceptives undergoing clinical trials. Dienogest, a progestogen, is known for its unique mechanism of action, while Estelle's novel estetrol component sets it apart from traditional oral contraceptives. Female population segments with specific health concerns, such as vitiligo patients and those at risk for osteoporosis, also contribute to the market's growth. These women require contraceptive solutions that cater to their unique health needs. The success of oral contraceptives has led to the exploration of alternative delivery methods.
Market Segmentation
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD Billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
Distribution Channel
Offline
Online
Product
Female contraceptive devices
Female contraceptive drugs
Geography
North America
Canada
US
Europe
France
APAC
China
Japan
South America
Middle East and Africa
By Distribution Channel Insights
The offline segment is estimated to witness significant growth during the forecast period. The market encompasses various products such as Male Condoms, Vaginal Rings, Subdermal Implants, Tablets (Oral Contraceptive Pills), Injectables, and more. These offerings are available through multiple channels, including Households, Clinics, and Hospitals. The market for female contraceptives is experiencing steady growth due to the increasing unmet needs and gender-based barriers to accessing contraceptives. Unintended pregnancies continue to be a concern, making the demand for effective and reliable contraceptive methods high. Major merchandisers, including specialty stores, supermarkets, and department stores, play a significant role in the distribution of these products. These merchandisers offer a wide range of brands and types of female contraceptives, contributing to the market's growth.
Additionally, they are expanding their reach to local and regional markets to cater to the increasing demand. Furthermore, there is a growing trend towards the development of male contraceptive methods. However, the market for male contraceptives is currently in its nascent stages, presenting significant opportunities for growth. As awareness about sexual and reproductive health continues to increase, the demand for effective and accessible contraceptive options is expected to rise.
Get a glance at the market share of various segments Request Free Sample
The Offline segment was valued at USD 10.45 billion in 2018 and showed a gradual increase during the forecast period.
Regional Insights
North America is estimated to contribute 37% to the growth of the gl
In 1991, the birth rate for girls aged 10 to 14 years in the United States stood at 1.4 births per every thousand girls. Since 1991, this rate has consistently decreased, dropping to .2 in the year 2023. This statistic depicts the number of births per thousand U.S. females aged 10 to 14 years between 1991 and 2023. Teenage pregnancy and contraception Over the years, the rate of teenage pregnancy and birth has declined in the United States, most likely due to lower rates of sexual activity in this age group as well as increased use of birth control methods. However, the use and accessibility of contraceptives remains a problem in many parts of the United States. For example, in 2021, only 21 percent of sexually active high school students reported using the birth control pill to prevent pregnancy before their last sexual intercourse. This rate was highest among white high students and lowest among Black students, with only 11 percent reporting use of the birth control pill before their last intercourse. Condom use is more prevalent among high school students than use of the pill, but still only just over half of high school students reported using a condom the last time they had sex as of 2021. Disparities in teenage pregnancy Although rates have decreased over the past decades, teenage pregnancy and birth rates in the U.S. are still higher than in other Western countries. Geographic, racial, and ethnic disparities in teen birth rates are still prevalent within the country. In 2023, teenage birth rates were highest among Native Hawaiian and Pacific Islanders. Other contributing factors to high teen birth rates also include poor socioeconomic conditions, low education, and low-income status.
This statistic shows the percentage of U.S. teenagers that used some contraception method during their last sexual intercourse from 1988 to 2015, by gender. According to the data, in 1988, 80 percent of female respondents indicated that they used some form of contraception at their most recent sexual encounter. Comparatively, between 2011 and 2015, 90 percent of female respondents indicated that they used contraception at their last sexual encounter.
We estimate the degree to which expanding access to long-acting reversible contraceptives (LARCs) can reduce teen birth rates by analyzing Colorado's Family Planning Initiative, the first large-scale policy intervention to expand access to LARCs in the United States. Using a difference-in-differences approach, we find that the $23M program reduced the teen birth rate in counties with clinics receiving funding by 6.4 percent over 5 years. These effects were concentrated in the second through fifth years of the program and in counties with relatively high poverty rates. State-level synthetic control estimates offer supporting evidence but suffer from a lack of power.
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2023 |
REGIONS COVERED | North America, Europe, APAC, South America, MEA |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2024 | 26.0(USD Billion) |
MARKET SIZE 2025 | 26.7(USD Billion) |
MARKET SIZE 2035 | 34.7(USD Billion) |
SEGMENTS COVERED | Contraceptive Method, Formulation Type, Distribution Channel, Age Group, Regional |
COUNTRIES COVERED | US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA |
KEY MARKET DYNAMICS | rising awareness of reproductive health, increasing demand for long-term contraception, government support and funding, technological advancements in contraceptives, growing focus on personalized healthcare solutions |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | Gedeon Richter, Johnson & Johnson, Amgen, Bayer, HRA Pharma, Mylan, Teva Pharmaceutical Industries, Merck & Co, Pfizer, BristolMyers Squibb, AbbVie, Ferring Pharmaceuticals, Zydus Cadila, Lupin Pharmaceuticals, Allergan |
MARKET FORECAST PERIOD | 2025 - 2035 |
KEY MARKET OPPORTUNITIES | Innovative contraceptive methods development, Eco-friendly contraceptive products, Digital health integration, Increased educational initiatives, Expansion in emerging markets |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 2.6% (2025 - 2035) |
This statistic shows the percentage of U.S. teenagers that used select contraception methods during their most recent sexual intercourse from 2011 to 2015, by gender. According to the data, **** percent of females used dual methods for their most recent intercourse. Comparatively, about ** percent of males used dual methods at their most recent intercourse as well.
CC0 1.0 Universal Public Domain Dedicationhttps://creativecommons.org/publicdomain/zero/1.0/
License information was derived automatically
The Data Center at the Guttmacher Institute is focused on providing information on the state, national, and international level related to reproductive and sexual health. Background The Data Center is maintained by the Guttmacher Institute. The Guttmacher Institute’s goal is to advance the sexual and reproductive health in the United States and worldwide through an interrelated program of social science research, policy analysis and public education designed to generate new ideas, encourage enlightened public debate and promote sound policy and program development. In 2009, Guttmacher was designated an official Collaborating Center for Reproductive Health by the World Health Organization and its regional office, the Pan American Health Organization. The Institute produces a wide range of publications and resources on topics pertaining to sexual and reproductive health, including International Perspectives on Sexual and Reproductive Health, the Guttmacher Policy Review and Perspectives on Sexual and Reproductive Health. The Data Center allows users to search on the national, inter national, and state level for specific laws and policies related to title X, family planning, abortion policies, contraceptive needs and services, and teen pregnancy. User functionality Users are able to search U.S. and state data as well as international data. State profiles and country summaries are provided and include synopses of the main legislation related to sexual and reproductive health in that area. Users are also able to customize domestic and international data by creating a specific table, tracking a specific trend, or generating a specific map. Users are able to select specific indicators including data related to abortions, adol escents, demographics, contraception, pregnancy, and services and financing. Data Notes Users are able to download reports and summaries in html or pdf formats. If users generate tables or maps they are created in html and excel formats. The source of the data is clearly labeled and provided for each table/report. There is no indication on the website as to how often the data is updated.
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2023 |
REGIONS COVERED | North America, Europe, APAC, South America, MEA |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2024 | 1596.9(USD Million) |
MARKET SIZE 2025 | 1664.0(USD Million) |
MARKET SIZE 2035 | 2500.0(USD Million) |
SEGMENTS COVERED | Application, Distribution Channel, End User, Formulation Type, Regional |
COUNTRIES COVERED | US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA |
KEY MARKET DYNAMICS | growing awareness of family planning, increase in women's health initiatives, convenience and ease of use, rising demand for non-invasive options, advancements in patch technology |
MARKET FORECAST UNITS | USD Million |
KEY COMPANIES PROFILED | Watson Pharmaceuticals, Novartis, Johnson & Johnson, Pfizer, SDL Pharma, HRA Pharma, Bayer, Teva Pharmaceuticals, Merck & Co., Eli Lilly, Mylan, Sandoz |
MARKET FORECAST PERIOD | 2025 - 2035 |
KEY MARKET OPPORTUNITIES | Rising demand for convenience, Increased awareness of contraceptive options, Growth in telehealth services, Expansion in emerging markets, Technological advancements in patch design |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.2% (2025 - 2035) |
https://www.verifiedmarketresearch.com/privacy-policy/https://www.verifiedmarketresearch.com/privacy-policy/
United States Contraceptive Devices Market size was valued at USD 5.12 Billion in 2023 and is projected to reach USD 6.82 Billion by 2031, growing at a CAGR of 5.93% from 2024 to 2031.
Key Market Drivers: Growing Knowledge and Education: Government programs and non-governmental groups have helped to raise knowledge about reproductive health and family planning, resulting in increased uptake of contraceptive devices. Campaigns to prevent unwanted pregnancies and sexually transmitted infections (STIs) have been vital. This has resulted in increasing adoption rates among several demographic groups, most notably teens and young adults.
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2023 |
REGIONS COVERED | North America, Europe, APAC, South America, MEA |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2024 | 1864.7(USD Million) |
MARKET SIZE 2025 | 1974.7(USD Million) |
MARKET SIZE 2035 | 3500.0(USD Million) |
SEGMENTS COVERED | Application, End Use, Type, Distribution Channel, Regional |
COUNTRIES COVERED | US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA |
KEY MARKET DYNAMICS | rising contraceptive awareness, convenience and ease of use, increasing healthcare expenditures, regulatory approvals and innovations, growing demand for hormonal contraceptives |
MARKET FORECAST UNITS | USD Million |
KEY COMPANIES PROFILED | Cipla, AstraZeneca, HRA Pharma, Teva Pharmaceuticals, Merck & Co, Hologic, Mylan, Lupin Pharmaceuticals, Impax Laboratories, Energizer Holdings, The Female Health Company, Pfizer, Novartis, Johnson & Johnson, Sandoz, Bayer |
MARKET FORECAST PERIOD | 2025 - 2035 |
KEY MARKET OPPORTUNITIES | Increased awareness of contraceptive options, Rise in teen pregnancy prevention initiatives, Growth in non-hormonal birth control demands, Demand for hormonal patch convenience, Expansion in telehealth and online consultations |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.9% (2025 - 2035) |
A 2021 survey of American high school students found that of those who were sexually active and engaging in sex with opposite-sex partners, 20.9 percent were using the birth control pill to prevent pregnancy. Prevalence was highest among female students.
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2023 |
REGIONS COVERED | North America, Europe, APAC, South America, MEA |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2024 | 4,200(USD Million) |
MARKET SIZE 2025 | 4,500(USD Million) |
MARKET SIZE 2035 | 8.5(USD Billion) |
SEGMENTS COVERED | Type, End User, Application, Distribution Channel, Regional |
COUNTRIES COVERED | US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA |
KEY MARKET DYNAMICS | increasing demand for contraceptives, rising awareness of family planning, technological advancements in LARC, government healthcare initiatives, growing teenage pregnancy rates |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | Bayer, Pfizer, Merck, Novartis, Cherokee Pharmaceuticals, Eli Lilly, Teva Pharmaceuticals, Mylan, Allergan, Ferring Pharmaceuticals, Agile Therapeutics, Impax Laboratories, Hologic, Daiichi Sankyo, CooperSurgical |
MARKET FORECAST PERIOD | 2025 - 2035 |
KEY MARKET OPPORTUNITIES | Increased awareness of LARC options, Rising demand for family planning solutions, Technological advancements in contraception, Expansion into emerging markets, Government support for women's health initiatives |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.5% (2025 - 2035) |
This statistic shows the percentage of U.S. female teenagers that used select contraception methods during their most recent sexual intercourse from 2011 to 2015, by ethnicity. According to the data, 86.9 percent of Hispanic or Latina U.S. female teenagers used any method of contraception during their last sexual intercourse.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Statement of the problemHispanic American adolescents experience high rates of pregnancy with profound consequences. Compared with White teens, Hispanic teens use contraception less frequently and often choose less effective forms of contraception. Access to contraception is a primary barrier to use which contributes to relatively high and disparate rates of pregnancy in Hispanic teens. This integrative review identifies facilitators and barriers of contraception access and use for Hispanic women, 13–17 years of age, living in the U.S.MethodologyFollowing the Whittemore and Knafl (2005) methodology and PRISMA guidelines, peer reviewed studies were retrieved from PUBMED, CINAHL and EMBASE. The Mixed Methods Appraisal Tool was used to assess the study quality and thematic analysis was used to categorize barriers and facilitators.FindingsOf 131 studies retrieved, 16 met inclusion criteria. Individual, interpersonal and healthcare provider factors were identified as primary categories of barriers and facilitators with structural issues comprising an additional barrier category. Individual level barriers were disproportionately represented and further categorized into themes: beliefs/misconceptions, dislike of contraception, pregnancy risk perception, lack of knowledge, and lack of control. Barriers related to cultural and religious influences were identified in individual, interpersonal and structural levels. The most frequently reported facilitators were perceived parent comfort discussing sexual health and past experience of pregnancy.DiscussionLimitations in this review may stem from heterogeneity in the acculturation and geography of participants and analysis by a single reviewer. Implications include considering the range of information sources and the influence they have on risk perception and risk mitigation for this population.Conclusion & significanceAdolescents describe many modifiable influences on contraception access and use. Misperceptions related to contraception, stemming from beliefs and perceptions, can be corrected through increased access to reliable sources of sex education, parental support, and direct access to nurses and healthcare providers. Awareness of these influences can inform further research and intervention development to address these health disparities.
https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
BASE YEAR | 2024 |
HISTORICAL DATA | 2019 - 2023 |
REGIONS COVERED | North America, Europe, APAC, South America, MEA |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
MARKET SIZE 2024 | 1,400(USD Million) |
MARKET SIZE 2025 | 1,500(USD Million) |
MARKET SIZE 2035 | 2,500(USD Million) |
SEGMENTS COVERED | Product Type, Distribution Channel, Age Group, Prescription Status, Regional |
COUNTRIES COVERED | US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA |
KEY MARKET DYNAMICS | Increasing teenage pregnancies, Growing awareness of contraceptives, Rising healthcare expenditures, Regulatory changes in pharmaceuticals, Shift towards online purchasing |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | Bayer, Pfizer, Continental Pharmaceuticals, Teva Pharmaceutical Industries, Mylan, Sandoz, HRA Pharma, Walgreens Boots Alliance, Hikma Pharmaceuticals, Ferring Pharmaceuticals, Cipla, GSK |
MARKET FORECAST PERIOD | 2025 - 2035 |
KEY MARKET OPPORTUNITIES | Rising awareness of contraceptive options, Increasing demand for emergency contraceptives, Expansion in developing markets, E-commerce growth for accessibility, Innovative product formulations and packaging |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.3% (2025 - 2035) |
This study was aimed at documenting the sexual behavior and practices of adolescent females in the U.S. Data on frequency of sexual behavior, use of contraception, pregnancy, childbearing and abortion were collected. Basic background information on subjects was also collected, to allow investigation of how sexual behavior varies as a function of background. This subset was prepared by Sociometrics Corp.
https://dataverse.harvard.edu/api/datasets/:persistentId/versions/3.0/customlicense?persistentId=doi:10.7910/DVN/8AHGR7https://dataverse.harvard.edu/api/datasets/:persistentId/versions/3.0/customlicense?persistentId=doi:10.7910/DVN/8AHGR7
Like the 1971 and 1976 National Surveys of Young Women, the major purpose of this study was to provide estimates of the prevalence of sexual activity, contraceptive use and non-use, premarital pregnancy and its resolution among teenage women. This study also attempted to determine how informed young men were about contraception and the menstrual cycle. This dataset is a subset of the full study, and was put together by Sociometrics Corp.
In 2020, the District of Columbia had the highest teenage pregnancy rate in the United States, followed by Mississippi and Arkansas. At that time, there were around 45 pregnancies among teens aged 15 to 19 per 1,000 in the District of Columbia. Teenage pregnancy Teenage pregnancy rates in the United States have decreased in recent years. In 2020, there were around 26.7 teenage pregnancies per 1,000 women aged 15 to 19 years. This number was almost 118 per 1,000 women in the year 1990. It is believed that the causes of this decrease include more teens abstaining from sex and increased use of birth control among those teens who are sexually active. Contraception use The use of contraception among sexually active teens is vital in reducing the rates of teen pregnancy. However, in 2021, only 52 percent of sexually active teens reported they used a condom during their last sexual intercourse. Furthermore, only 23 percent of sexually active female high school students were using the birth control bill to prevent pregnancy. Access to contraception and taboos surrounding teen sexual activity remain barriers to contraceptive use among teens in many areas of the United States.